Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CD15 is a risk predictor and a novel target in clear cell renal cell carcinoma.
Stenzel PJ, Schindeldecker M, Seidmann L, Herpel E, Hohenfellner M, Hatiboglu G, Foersch S, Porubsky S, Macher-Goeppinger S, Roth W, Tagscherer KE. Stenzel PJ, et al. Among authors: hatiboglu g. Pathobiology. 2023 Nov 14. doi: 10.1159/000535201. Online ahead of print. Pathobiology. 2023. PMID: 37963432
Lamin-B1 is a senescence-associated biomarker in clear-cell renal cell carcinoma.
Radspieler MM, Schindeldecker M, Stenzel P, Försch S, Tagscherer KE, Herpel E, Hohenfellner M, Hatiboglu G, Roth W, Macher-Goeppinger S. Radspieler MM, et al. Among authors: hatiboglu g. Oncol Lett. 2019 Sep;18(3):2654-2660. doi: 10.3892/ol.2019.10593. Epub 2019 Jul 9. Oncol Lett. 2019. PMID: 31402955 Free PMC article.
Prognostic and Predictive Value of Tumor-infiltrating Leukocytes and of Immune Checkpoint Molecules PD1 and PDL1 in Clear Cell Renal Cell Carcinoma.
Stenzel PJ, Schindeldecker M, Tagscherer KE, Foersch S, Herpel E, Hohenfellner M, Hatiboglu G, Alt J, Thomas C, Haferkamp A, Roth W, Macher-Goeppinger S. Stenzel PJ, et al. Among authors: hatiboglu g. Transl Oncol. 2020 Feb;13(2):336-345. doi: 10.1016/j.tranon.2019.11.002. Epub 2019 Dec 24. Transl Oncol. 2020. PMID: 31881506 Free PMC article.
Prognostic factors influencing long-term survival of patients undergoing nephron-sparing surgery for nonmetastatic renal-cell carcinoma (RCC) with imperative indications.
Haferkamp A, Kurosch M, Pritsch M, Hatiboglu G, Macher-Goeppinger S, Pfitzenmaier J, Pahernik S, Wagener N, Hohenfellner M. Haferkamp A, et al. Among authors: hatiboglu g. Ann Surg Oncol. 2010 Feb;17(2):544-51. doi: 10.1245/s10434-009-0812-y. Epub 2009 Dec 1. Ann Surg Oncol. 2010. PMID: 19953334
Genomic features of renal cell carcinoma with venous tumor thrombus.
Warsow G, Hübschmann D, Kleinheinz K, Nientiedt C, Heller M, Van Coile L, Tolstov Y, Trennheuser L, Wieczorek K, Pecqueux C, Gasch C, Kuru T, Nyarangi-Dix J, Hatiboglu G, Teber D, Perner S, Stenzinger A, Roth W, Hadaschik B, Pahernik S, Jäger D, Grüllich C, Duensing A, Eils R, Schlesner M, Sültmann H, Hohenfellner M, Duensing S. Warsow G, et al. Among authors: hatiboglu g. Sci Rep. 2018 May 10;8(1):7477. doi: 10.1038/s41598-018-25544-z. Sci Rep. 2018. PMID: 29748622 Free PMC article.
Spatial niche formation but not malignant progression is a driving force for intratumoural heterogeneity.
Hoefflin R, Lahrmann B, Warsow G, Hübschmann D, Spath C, Walter B, Chen X, Hofer L, Macher-Goeppinger S, Tolstov Y, Korzeniewski N, Duensing A, Grüllich C, Jäger D, Perner S, Schönberg G, Nyarangi-Dix J, Isaac S, Hatiboglu G, Teber D, Hadaschik B, Pahernik S, Roth W, Eils R, Schlesner M, Sültmann H, Hohenfellner M, Grabe N, Duensing S. Hoefflin R, et al. Among authors: hatiboglu g. Nat Commun. 2016 Jun 13;7:ncomms11845. doi: 10.1038/ncomms11845. Nat Commun. 2016. PMID: 27291893 Free PMC article.
Effective downsizing but enhanced intratumoral heterogeneity following neoadjuvant sorafenib in patients with non-metastatic renal cell carcinoma.
Hatiboglu G, Hohenfellner M, Arslan A, Hadaschik B, Teber D, Radtke JP, Hallscheidt P, Tolstov Y, Roth W, Grüllich C, Huesing J, Duensing S, Pahernik S. Hatiboglu G, et al. Langenbecks Arch Surg. 2017 Jun;402(4):637-644. doi: 10.1007/s00423-016-1543-8. Epub 2016 Dec 23. Langenbecks Arch Surg. 2017. PMID: 28012035 Clinical Trial.
The impact of type 2 diabetes on the outcome of localized renal cell carcinoma.
Höfner T, Zeier M, Hatiboglu G, Eisen C, Schönberg G, Hadaschik B, Teber D, Duensing S, Trumpp A, Hohenfellner M, Pahernik S. Höfner T, et al. Among authors: hatiboglu g. World J Urol. 2014 Dec;32(6):1537-42. doi: 10.1007/s00345-013-1231-z. Epub 2013 Dec 27. World J Urol. 2014. PMID: 24370691
70 results